Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus
Status:
Completed
Trial end date:
2019-09-18
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness and safety of an investigational drug, IV
ganaxolone, as adjunctive therapy to standard of care to treat subjects with status
epilepticus.